Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum

Citation
Ak. Srivastava et al., Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum, BONE, 27(4), 2000, pp. 529-533
Citations number
15
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","da verificare
Journal title
BONE
ISSN journal
87563282 → ACNP
Volume
27
Issue
4
Year of publication
2000
Pages
529 - 533
Database
ISI
SICI code
8756-3282(200010)27:4<529:DAEOCE>2.0.ZU;2-C
Abstract
The mouse is increasingly being used as an animal model for the study of sk eletal phenotypes in humans, mainly because of the ease of genetic manipula tion. Biochemical markers of bone metabolism provide a valuable parameter f or the assessment of skeletal metabolism, In the mouse model, assays for bo ne formation have been available for a long time; however, little is known about bone resorption markers. The present study describes the development of a serum C-telopeptide enzyme-linked immunoassay (ELISA), which measures degradation products of type I collagen that are generated by osteoclastic bone resorption, The C-telopeptide ELISA uses affinity-purified antibodies generated against human sequence DFSFLPQPPQEKAHDGGR, The epitope involves a n amino acid sequence, which is identical in the mouse and human C-terminal peptide of type I collagen (alpha 1 chain). Sensitivity of the ELISA used was <0.1 ng/mL, The average intra- (n = 10) and interassay (n = 8) coeffici ent of variation for two controls was <12%, The average dilution and spike recovery rates were 98% and 97%, respectively. Application of the ELISA to measure C-telopeptide in 3-4-week postovariectomized (ovx) C57BL/6J (B6) mi ce (n = 9 or 10) showed a 45% higher C-telopeptide concentration than the s ham-operated mice. Treatment of ovx mice with estradiol (400 mu g/kg body w eight) or alendronate (1.0 mg/kg body weight) resulted in a 20%-50% decreas e in C-telopeptide levels compared to the vehicle-treated ovx group. In add ition, B6 mice fed a calcium-deficient diet (0.01% calcium) showed a 50% hi gher C-telopeptide concentration compared to the B6 mice receiving a normal diet (0.6% calcium), In conclusion, the C-telopeptide ELISA exhibited acce ptable analytical performance and sufficient discriminatory power to show e xpected directional changes in the rate of bone resorption following ovarie ctomy, ovx plus estradiol or alendronate treatment, and administration of a calcium-deficient diet. Therefore, the ELISA developed in this study could be used for measuring bone resorption in the mouse model, (Bone 27: 529-53 3; 2000) (C) 2000 by Elsevier Science Inc. All rights reserved.